acquisition: have popular in firms competing in global economy strategies

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents development
Weight: 0.69
, share
Weight: 0.64
, agreement
Weight: 0.63
, business activity
Weight: 0.63
Siblings deal
Weight: 0.65
, purchase
Weight: 0.62
, takeover
Weight: 0.50
, merger
Weight: 0.36
, partnership
Weight: 0.33

Related properties

Property Similarity
have popular in firms competing in global economy strategies 1.00
have popular in many firms competing in global economy strategies 1.00
be in companies 0.84
be very profitable for companies 0.81
be very profitable for pharmaceutical companies 0.80
be important in business 0.78
be in technology industry 0.78
be important to global health 0.78
be good in business 0.77
be better for business 0.77

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.50
Rule weight: 0.66
Evidence weight: 0.93
Similarity weight: 0.80
Evidence: 0.93
Plausible(development, be very profitable for pharmaceutical companies) ⋁
Evidence: 1.00
¬ Typical(acquisition, have popular in firms competing in global economy strategies)
0.37
Rule weight: 0.66
Evidence weight: 0.67
Similarity weight: 0.84
Evidence: 0.67
Plausible(share, be in companies) ⋁
Evidence: 1.00
¬ Typical(acquisition, have popular in firms competing in global economy strategies)

Plausibility inheritance from parent to child

0.08
Rule weight: 0.09
Evidence weight: 0.98
Similarity weight: 0.84
Evidence: 0.97
Plausible(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.67
¬ Plausible(share, be in companies)
0.07
Rule weight: 0.09
Evidence weight: 0.97
Similarity weight: 0.80
Evidence: 0.97
Plausible(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.93
¬ Plausible(development, be very profitable for pharmaceutical companies)

Remarkability exclusitivity betweem a parent and a child

0.28
Rule weight: 0.58
Evidence weight: 0.61
Similarity weight: 0.80
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.66
¬ Remarkable(development, be very profitable for pharmaceutical companies)
0.22
Rule weight: 0.58
Evidence weight: 0.45
Similarity weight: 0.84
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.94
¬ Remarkable(share, be in companies)

Remarkability exclusitivity between siblings

0.09
Rule weight: 0.13
Evidence weight: 0.66
Similarity weight: 1.00
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.57
¬ Remarkable(merger, have popular in firms competing in global economy strategies)
0.09
Rule weight: 0.13
Evidence weight: 0.66
Similarity weight: 1.00
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.57
¬ Remarkable(merger, have popular in many firms competing in global economy strategies)
0.06
Rule weight: 0.13
Evidence weight: 0.60
Similarity weight: 0.77
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.69
¬ Remarkable(partnership, be better for business)
0.06
Rule weight: 0.13
Evidence weight: 0.55
Similarity weight: 0.77
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.77
¬ Remarkable(partnership, be good in business)
0.05
Rule weight: 0.13
Evidence weight: 0.50
Similarity weight: 0.78
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.85
¬ Remarkable(partnership, be important in business)
0.05
Rule weight: 0.13
Evidence weight: 0.50
Similarity weight: 0.78
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.85
¬ Remarkable(partnership, be important to global health)
0.04
Rule weight: 0.13
Evidence weight: 0.43
Similarity weight: 0.78
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.97
¬ Remarkable(deal, be in technology industry)

Remarkability from parent implausibility

0.33
Rule weight: 0.42
Evidence weight: 0.97
Similarity weight: 0.80
Evidence: 0.93
Plausible(development, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.58
Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.97
¬ Plausible(acquisition, have popular in firms competing in global economy strategies)
0.30
Rule weight: 0.42
Evidence weight: 0.87
Similarity weight: 0.84
Evidence: 0.67
Plausible(share, be in companies) ⋁
Evidence: 0.58
Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.97
¬ Plausible(acquisition, have popular in firms competing in global economy strategies)

Remarkability from sibling implausibility

0.59
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 1.00
Evidence: 0.97
Plausible(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.57
Remarkable(merger, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.83
¬ Plausible(merger, have popular in firms competing in global economy strategies)
0.59
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 1.00
Evidence: 0.97
Plausible(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.57
Remarkable(merger, have popular in many firms competing in global economy strategies) ⋁
Evidence: 0.81
¬ Plausible(merger, have popular in many firms competing in global economy strategies)
0.47
Rule weight: 0.60
Evidence weight: 1.00
Similarity weight: 0.78
Evidence: 0.97
Plausible(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.97
Remarkable(deal, be in technology industry) ⋁
Evidence: 0.32
¬ Plausible(deal, be in technology industry)
0.47
Rule weight: 0.60
Evidence weight: 1.00
Similarity weight: 0.78
Evidence: 0.97
Plausible(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.85
Remarkable(partnership, be important in business) ⋁
Evidence: 0.57
¬ Plausible(partnership, be important in business)
0.47
Rule weight: 0.60
Evidence weight: 1.00
Similarity weight: 0.78
Evidence: 0.97
Plausible(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.85
Remarkable(partnership, be important to global health) ⋁
Evidence: 0.57
¬ Plausible(partnership, be important to global health)
0.46
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.77
Evidence: 0.97
Plausible(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.77
Remarkable(partnership, be good in business) ⋁
Evidence: 0.66
¬ Plausible(partnership, be good in business)
0.46
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.77
Evidence: 0.97
Plausible(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.69
Remarkable(partnership, be better for business) ⋁
Evidence: 0.68
¬ Plausible(partnership, be better for business)

Salient implies Plausible

0.27
Rule weight: 0.28
Evidence weight: 0.97
Similarity weight: 1.00
Evidence: 0.97
Plausible(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 1.00
¬ Salient(acquisition, have popular in firms competing in global economy strategies)

Similarity expansion

0.85
Rule weight: 0.85
Evidence weight: 1.00
Similarity weight: 1.00
Evidence: 1.00
Salient(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 1.00
¬ Salient(acquisition, have popular in many firms competing in global economy strategies)
0.85
Rule weight: 0.85
Evidence weight: 1.00
Similarity weight: 1.00
Evidence: 1.00
Typical(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 1.00
¬ Typical(acquisition, have popular in many firms competing in global economy strategies)
0.82
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 1.00
Evidence: 0.97
Plausible(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.97
¬ Plausible(acquisition, have popular in many firms competing in global economy strategies)
0.64
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 1.00
Evidence: 0.58
Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.58
¬ Remarkable(acquisition, have popular in many firms competing in global economy strategies)

Typical and Remarkable implies Salient

0.14
Rule weight: 0.14
Evidence weight: 1.00
Similarity weight: 1.00
Evidence: 1.00
Salient(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 1.00
¬ Typical(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies)

Typical implies Plausible

0.46
Rule weight: 0.48
Evidence weight: 0.97
Similarity weight: 1.00
Evidence: 0.97
Plausible(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 1.00
¬ Typical(acquisition, have popular in firms competing in global economy strategies)

Typicality and Rermarkability incompatibility between a parent and a child

0.42
Rule weight: 0.51
Evidence weight: 0.98
Similarity weight: 0.84
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.04
¬ Typical(share, be in companies)
0.18
Rule weight: 0.51
Evidence weight: 0.44
Similarity weight: 0.80
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.96
¬ Typical(development, be very profitable for pharmaceutical companies)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.95
Similarity weight: 0.78
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.09
¬ Typical(deal, be in technology industry)
0.08
Rule weight: 0.14
Evidence weight: 0.72
Similarity weight: 0.78
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.47
¬ Typical(partnership, be important to global health)
0.08
Rule weight: 0.14
Evidence weight: 0.72
Similarity weight: 0.78
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.48
¬ Typical(partnership, be important in business)
0.07
Rule weight: 0.14
Evidence weight: 0.49
Similarity weight: 1.00
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.87
¬ Typical(merger, have popular in many firms competing in global economy strategies)
0.07
Rule weight: 0.14
Evidence weight: 0.48
Similarity weight: 1.00
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.89
¬ Typical(merger, have popular in firms competing in global economy strategies)
0.06
Rule weight: 0.14
Evidence weight: 0.62
Similarity weight: 0.77
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.64
¬ Typical(partnership, be good in business)
0.06
Rule weight: 0.14
Evidence weight: 0.59
Similarity weight: 0.77
Evidence: 0.58
¬ Remarkable(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.70
¬ Typical(partnership, be better for business)

Typicality inheritance from parent to child

0.41
Rule weight: 0.48
Evidence weight: 1.00
Similarity weight: 0.84
Evidence: 1.00
Typical(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.04
¬ Typical(share, be in companies)
0.39
Rule weight: 0.48
Evidence weight: 1.00
Similarity weight: 0.80
Evidence: 1.00
Typical(acquisition, have popular in firms competing in global economy strategies) ⋁
Evidence: 0.96
¬ Typical(development, be very profitable for pharmaceutical companies)